Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Paul Medical gets 510(k) for needleless intraveneous (IV) system:

This article was originally published in Clinica

Executive Summary

St Paul Medical has received US FDA clearance to market its needleless IV system. Key-Lok uses blunt plastic cannulae in place of needles and latex-free female connector ports to reduce the chance of needlestick injuries and allergic responses. The American Journal of Infection Control estimates that there are 800,000 accidental needlestick injuries in the US every year. Some 16,000 healthcare workers are exposed to HIV and 130,000 to hepatitis B, incurring diagnosis and treatments costs of around $2,000 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087049

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel